BioSpace News Archive

Lone Star Bio

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Retractable Technologies, Inc. announced that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.

June 30, 2022
·
2 min read
BioMidwest

Neurotech Startup Canaery Secures Over $4 Million in Seed Funding to Digitize the Sense of Smell

Canaery, the neurotech startup digitizing the sense of smell to enhance the way we perceive and monitor the world around us, announced it has closed more than $4 million in seed funding to accelerate the development of its scent-sensing platform.

June 30, 2022
·
3 min read
FDA

Phanes Therapeutics’ PT886 granted Orphan Drug Designation for the treatment of pancreatic cancer by the FDA

Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to PT886 for the treatment of pancreatic cancer.

June 30, 2022
·
2 min read
Business

Integer Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022

Integer Holdings Corporation announced that it plans to release financial and operational results for second quarter 2022, at 7 a.m. Central Time / 8 a.m. Eastern Time on Thursday, July 28, 2022.

June 30, 2022
·
1 min read
Business

Achilles Therapeutics Appoints James Taylor as Chief Business Officer and Cassian Yee, MD to Scientific Advisory Board

Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the appointment of James Taylor as Chief Business Officer and Cassian Yee, MD to its Scientific Advisory Board (SAB), effective July 1, 2022.

June 30, 2022
·
2 min read
Genetown

Albireo to Present at the William Blair Biotech Focus Conference 2022

Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced participation at the William Blair Biotech Focus Conference July 12-13, 2022.

June 30, 2022
·
1 min read
Business

NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer

William J. Rieflin to transition from Executive Chairman to Chairman of the Board of Directors.

June 30, 2022
·
8 min read
Nanostics Announces Study Data Supporting ClarityDX Prostate as a Reflex Test to Predict Clinically Significant Prostate Cancer

Real-world data shows that at a 94% sensitivity level for prostate cancer ClarityDX Prostate ® is 147% more specific than the PSA test for predicting clinically significant prostate cancer.

June 30, 2022
·
3 min read
Business

Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners

HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from Ardelyx Japanese collaboration partner.

June 30, 2022
·
5 min read
Genetown

NeuroSense Therapeutics Reports Positive Preliminary Results from Novel Alzheimer’s Biomarker Study

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced results from a biomarker study conducted to evaluate the potential of CogniC, NeuroSense’s combination drug for the treatment of Alzheimer’s disease (AD).

June 30, 2022
·
5 min read